AKTX

7.1807.00%
RP

Raymond Prudo-Chlebosz

Independent Director

Dr. Raymond Prudo-Chlebosz, M.D., also known as Ray, is Independent Director of Akari Therapeutics, Plc. He was the Executive Chairman of Akari Therapeutics, Plc since September 2015 until December 31, 2022 and served as its Chairman since January 01, 2023 and serves as its Director from September 2015. Dr. Prudo is also the cofounder of The Doctors’ Laboratory (“TDL”), past CEO and its Chairman since 2002. Since 2015 he has also been a director of Health Services Laboratories (“HSL”). Both TDL and HSL are subsidiaries of Sonic Healthcare Limited. Dr. Prudo-Chlebosz has been an active investor and developer of healthcare companies for many years. Dr. Prudo-Chlebosz is the Founder of Volution and served as Chairman and Chief Executive Officer. He worked at Varleigh Immuno Pharmaceuticals since inception in 2008. He served as Interim Chief Executive Officer at Akari Therapeutics, Plc since May 29, 2017. He serves as a board member of several UK healthcare companies. Dr. Prudo-Chlebosz holds an MBBS from the University of London and an FRCP(C) from the Royal College of Physicians and Surgeons of Canada.

Positions